Cochrane Database of Systematic Reviews 2008
Acyclovir for treating primary herpetic gingivostomatitis
Abstract: We found two relevant trials in this systematic review, only one of them could provide some weak evidence that acyclovir is an effective treatment in reducing the number of oral lesions, preventing the development of new extraoral lesions, decreasing the number of individuals with difficulties experienced in eating and drinking and reducing hospital admission for children under 6 years of age with primary herpetic gingivostomatitis.
Search citation statements
Paper Sections
Select...
45
0
0
0
Citation Types
0
7
0
0
Year Published
Range
2000
2026
Publication Types
Select...
25
19
1
Relationship
0
45
Authors
Journals
Cited by 45 publications
(7 citation statements)
References 12 publications
0
7
0
0
Smart CitationsHow this paper cites the one you are viewing
“…Because of the patient’s discomfort and the prolonged ICU treatment, oral aciclovir therapy 400 mg five times daily was administered, which resulted in rapid improvement of pain and ulcerations 4 . Given the patient’s age and the rare secondary manifestation of HSV‐1 in the oral cavity, we believe that the COVID‐19 infection and prolonged inpatient care were causal factors of stress induction and immunosuppression, leading to the distinct oral manifestations.…”
Section: Figure
mentioning
confidence: 99%